IncFact
Company Profiles: Revenue, Growth, Competition

FOGHORN THERAPEUTICS Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Foghorn Therapeutics

Access the complete profile.

Foghorn Therapeutics Fast Facts

Revenue$10 - $50 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes32541
Address161 1st St Ste 2a
Cambridge, MA 02142

Note: Revenues for privately held companies are statistical evaluations.


Foghorn Therapeutics's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.


Foghorn Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Foghorn Therapeutics Annual Revenue and Growth Rate

Foghorn Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2018 Details in Premium Report
2017
2016
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Foghorn Therapeutics's revenues are gauged from an analysis of company filings.



Foghorn Therapeutics's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Foghorn Therapeutics Revenue (Sales) Foghorn Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Foghorn Therapeutics is developing and marketing. Foghorn Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
GENE TRAFFIC CONTROL
Agents for scientific and research use, namely, pharmaceutical agents that modulate epigenetic mechanisms to treat disease for use in the field of biotechnology; chemical agents for use in the research, discovery and development of pharmaceuticals and research on epigenetic structures and functions; reagents for scientific and medical research use; Agents for medical and veterinary use, namely, pharmaceutical preparations for the treatment of diseases and disorders, namely, oncological, neurological, developmental, hematological, bone, respiratory, central nervous system, endrocrinological, metabolic, circulatory, gastroenterological, hormonal and diabetic disorders; pharmaceuticals, namely, epigenetic modulating agents and chromatin regulating agents to treat disease; diagnostic agents, preparations and substances for medical purposes; Platform featuring epigenetic modulating agents and chromatin regulating agents to treat disease
03/19/2018
GTC
Agents for scientific and research use, namely, pharmaceutical agents that modulate epigenetic mechanisms to treat disease for use in the field of biotechnology; chemical agents for use in the research, discovery and development of pharmaceuticals and research on epigenetic structures and functions; reagents for scientific and medical research use; Agents for medical and veterinary use, namely, pharmaceutical preparations for the treatment of diseases and disorders, namely, oncological, neurological, developmental, hematological, bone, respiratory, central nervous system, endrocrinological, metabolic, circulatory, gastroenterological, hormonal and diabetic disorders; pharmaceuticals, namely, epigenetic modulating agents and chromatin regulating agents to treat disease; diagnostic agents, preparations and substances for medical purposes; Platform featuring epigenetic modulating agents and chromatin regulating agents to treat disease
03/19/2018
FOGHORN
Agents for scientific and research use, namely, pharmaceutical agents that modulate epigenetic mechanisms to treat disease for use in the field of biotechnology; chemical agents for use in the research, discovery and development of pharmaceuticals and research on epigenetic structures and functions; reagents for scientific and medical research use
11/16/2015

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Foghorn Therapeutics grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Foghorn Therapeutics is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Foghorn Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Foghorn Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
PANACEA BIOMATXResearch Triangle Park, NC100 
THERADAPTIVELexington, MA46 
BETULA EXTRACTIVESWaconia, MN20 




Nearby Competitors

These companies are similar in business line and location to Foghorn Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ABCAMCambridge, MA100 
BRAINTREE LABORATORIESBraintree, MA74 
MERRIMACK PHARMACEUTICALSCambridge, MA66 
RUBIUS THERAPEUTICSCambridge, MA46 
SERVIER PHARMACEUTICALSBoston, MA37 
FOGHORN THERAPEUTICSCambridge, MA18 




Future Competition: Foghorn Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Foghorn Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Foghorn Therapeutics Competitors